)
Philogen (PHIL) investor relations material
Philogen Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Ended Q1 2026 with a positive net financial position of €355.4 million, down 3.5% from December 31, 2025.
Cash and cash equivalents totaled €366.1 million, a 3.4% decrease from year-end 2025, mainly due to operating costs, capital expenditures, treasury share purchases, and financial operations.
Industrial programs are progressing as planned, with no significant changes to previously communicated timelines.
Financial highlights
Net financial debt decreased to €355.4 million as of March 31, 2026, from €368.3 million at year-end 2025.
Cash and cash equivalents declined by €13.1 million, primarily due to €9.4 million in operating costs and €4.4 million in net negative financial operations.
Current and non-current financial debt decreased by 2.1% to €10.7 million, consisting solely of lease liabilities.
Outlook and guidance
Industrial programs, including key clinical trials, are proceeding according to expected methods and timelines, with encouraging results.
- Record profit, €379.2M cash, €0.70 dividend, and major licensing deal drove FY2025 growth.PHIL
H2 20253 Apr 2026 - Strong clinical and regulatory momentum for targeted oncology therapies, with key trial readouts ahead.PHIL
Status Update3 Feb 2026 - Revenues fell sharply, losses widened, but late-stage pipeline and liquidity remain strong.PHIL
H1 202420 Jan 2026 - Q3 2024 net financial position is €42.96M, with pivotal trials and revenues set for record growth.PHIL
Q3 202411 Jan 2026 - Revenues tripled, net profit surged, and pivotal oncology trial readouts are due in 2025.PHIL
H2 202418 Dec 2025 - Q3 2025 net financial position soared to €369.2M, supporting expanded clinical and R&D activity.PHIL
Q3 202511 Nov 2025 - Licensing deals drove liquidity surge, pipeline progress, and improved financial performance.PHIL
H1 202526 Sep 2025 - Q1 2025 net financial position at €93.6M, with clinical and R&D progress on track.PHIL
Q1 20256 Jun 2025
Next Philogen earnings date
Next Philogen earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)